National HealthCare Corporation (NHC)
Return on equity (ROE)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 66,798 | 22,445 | 138,590 | 41,871 | 68,211 |
| Total stockholders’ equity | US$ in thousands | 908,752 | 874,276 | 903,004 | 795,177 | 778,593 |
| ROE | 7.35% | 2.57% | 15.35% | 5.27% | 8.76% |
December 31, 2023 calculation
ROE = Net income ÷ Total stockholders’ equity
= $66,798K ÷ $908,752K
= 7.35%
The return on equity (ROE) for National Healthcare Corp. has shown fluctuations over the past five years. In 2023, the ROE stands at 7.35%, indicating that for every dollar of shareholders' equity, the company generated a return of 7.35%. This represents an improvement compared to the previous year, where the ROE was 2.57%.
In 2021, National Healthcare Corp. achieved a high ROE of 15.35%, suggesting efficient utilization of equity to generate profits. However, this figure decreased in 2022 and 2023, possibly due to various factors such as changes in the company's financial structure, profitability, or operational efficiency.
Overall, the ROE trend for National Healthcare Corp. shows variability, with fluctuations in performance levels over the years. It is essential for investors and stakeholders to assess the reasons behind these fluctuations to gain a deeper understanding of the company's financial health and performance.
Peer comparison
Dec 31, 2023